Table 4 Univariate analysis of predictors for adverse surgical outcome
Parameter | Number | Adverse surgical outcomea | Pb |
|---|---|---|---|
Total | 335 | 174 (52%) | |
Sex (n, %) | 0.389 | ||
Male | 290 | 152 (53%) | |
Female | 45 | 22 (49%) | |
ASA score (n, %) | 0.002 | ||
1 – 2 | 193 | 87 (45%) | |
3 – 4 | 142 | 87 (61%) | |
BMI | 0.252 | ||
<25 kg/m2 | 179 | 96 (53%) | |
≥25 kg/m2 | 154 | 76 (49%) | |
Recent Smoking (n, %) | 0.036 | ||
Yes | 170 | 97 (57%) | |
None | 165 | 77 (47%) | |
Multimodal therapy (n, %) | 0.081 | ||
None | 73 | 43 (59%) | |
Neoadjuvant radiochemotherapy | 189 | 101 (53%) | |
Perioperative chemotherapy | 73 | 30 (41%) | |
Surgical approach (n, %) | 0.342 | ||
Thoracoabdominal | 309 | 159 (52%) | |
Transhiatal | 26 | 15 (58%) | |
Reconstruction (n, %) | 0.036 | ||
Gastric tube | 321 | 163 (51%) | |
Colon interposition | 14 | 11 (79%) | |
Anastomosis (n, %) | 0.017 | ||
Intrathoracic | 185 | 88 (59%) | |
Cervical | 150 | 86 (47%) | |
Tumor histological type (n, %) | 0.383 | ||
Squamous cell carcinoma | 137 | 73 (53%) | |
Adenocarcinoma | 198 | 101 (51%) | |
UICC-Stage (n, %) | 0.149 | ||
1 – 2 | 251 | 135 (54%) | |
3 – 4 | 84 | 39 (46%) | |
Treatment period | 0.015 | ||
1996 – 2005 | 159 | 93 (53%) | |
2006 – 2014 | 176 | 81 (46%) | |
Perioperative blood transfusion | 0.038 | ||
Yes | 203 | 112 (55%) | |
No | 126 | 56 (44%) | |
Intraoperative fluid rate | 0.479 | ||
<13 ml/kg/h | 166 | 85 (51%) | |
≥13 ml/kg/h | 167 | 87 (52%) | |
Fluid balance POD 0 | 0.001 | ||
<6000 ml | 166 | 71 (43%) | |
≥6000 ml | 166 | 100 (61%) | |
Fluid balance POD 4 | 0.001 | ||
<5500 ml | 164 | 69 (42%) | |
≥5500 ml | 165 | 99 (60%) |